Financials data is unavailable for this security.
View more
Year on year MatsukiyoCocokara & Co grew revenues 7.49% from 951.25bn to 1.02tn while net income improved 29.10% from 40.55bn to 52.35bn.
Gross margin | 34.73% |
---|---|
Net profit margin | 5.06% |
Operating margin | 7.12% |
Return on assets | 7.43% |
---|---|
Return on equity | 10.33% |
Return on investment | 9.59% |
More ▼
Cash flow in JPYView more
In 2024, MatsukiyoCocokara & Co increased its cash reserves by 23.62%, or 22.50bn. The company earned 63.51bn from its operations for a Cash Flow Margin of 6.21%. In addition the company used 22.76bn on investing activities and also paid 18.27bn in financing cash flows.
Cash flow per share | 179.83 |
---|---|
Price/Cash flow per share | 11.58 |
Book value per share | 1,241.32 |
---|---|
Tangible book value per share | 925.09 |
More ▼
Balance sheet in JPYView more
Current ratio | 2.17 |
---|---|
Quick ratio | 1.31 |
Total debt/total equity | 0.0376 |
---|---|
Total debt/total capital | 0.0362 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 57.14% and 30.51%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Drugs) industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg) | 1.42% |
---|---|
Div growth rate (5 year) | 11.10% |
Payout ratio (TTM) | 29.45% |
EPS growth(5 years) | 9.45 |
---|---|
EPS (TTM) vs TTM 1 year ago | 17.56 |
More ▼